Formulation of nanosuspensions of gymnemic acids for oral administration

International Journal of Nanoparticles

Volumn 3, Issue 4, 2010, Pages 309-325

  Ravichandran, R ^a  

^a National Council of Educational Research and Training India   (India)

Author keywords

Dissolution behaviour; Gymnemic acids; Nanocrystals; Nanoparticles

Indexed keywords

EID: 78649542949     PISSN: 17532507     EISSN: 17532515     Source Type: Journal    
DOI: 10.1504/IJNP.2010.037135     Document Type: Article

References (50)

1. Arunkumar, N., Deecaraman, M. and Rani, C. (2009) 'Nanosuspension technology and its applications in drug delivery', Asian Journal of Pharmaceutics, Vol. 3, No. 3, pp.168-173.
2. Asare-Anane, H., Huang, G.C., Amiel, S.A., Jones, P.M. and Persaud, S.J. (2005) 'Stimulation of insulin secretion by an aqueous extract of gymnema sylvestre: role of intracellular calcium', Endocrine Abstracts, Vol. 10, DP1.
3. Auweter, H., Bohn, H., Heger, R., Horn, D., Siegel, B. and Siemensmeyer, K. (2002) Precipitated Water-insoluble Colorants in Colloid Disperse Form, United States Patent 6,494,924.
4. Buckton, G. and Beezer, A.E. (1992) 'The relationship between particle size and solubility', Int. J. Pharm., Vol. 82, R7-R10.
5. Busignies, V., Leclerc, B., Porion, P., Evesque, P., Couarraze, G. and Tchoreloff, P. (2006) 'Compaction behaviour and new predictive approach to the compressibility of binary mixtures of pharmaceutical excipients', Eur. J. Pharm. Biopharm., Vol. 64, pp.66-74.
6. CSIR (2009) The Useful Plants of India, Publication and Information Directorate, New Delhi.
7. Faraji, A.H. and Wipf, P. (2009) 'Nanoparticles in cellular drug delivery', Bioorganic & Medicinal Chemistry, Vol. 17, No. 8, pp.2950-2962.
8. Fichtinger, A. (2004) Untersuchungen zur Stabilität, Lösungsgeschwindigkeit und Sättigungslöslichkeit von Cyclosporin-Nanosuspensionen, Diplom, Freie Universität, Berlin.
9. Gholap, S. and Kar, A. (2005) 'Gymnemic acids from gymnema sylvestre potentially regulates dexamethasone-induced hyperglycemia in mice', Pharmaceutical Biology, Vol. 43, No. 2, pp.192-195.
10. Hecq, J., Deleers, M., Fanara, D., Vranckx, H. and Amighi, K. (2005) 'Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine', Int. J. Pharm., Vol. 299, pp.167-177.
11. Hintz, R.J. and Johnson, K.C. (1989) 'The effect of particle size distribution on dissolution rate and oral absorption', Int. J. Pharm., Vol. 51, pp.9-17.
12. Hong-Min, L., Fumiyuki, K. and Yoshisuke, T. (1992) 'Isolation and structure elucidation of gymnemic acids, antisweet principles gymnema sylvestre', Chem. Pharm. Bull., Vol. 40, No. 6, pp.1366-1375.
13. Hu, J., Johnston, K.P. and Williams R.O., 3rd (2004) 'Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs', Drug Dev. Ind. Pharm., Vol. 30, pp.233-245.
14. Indian Medicinal Plants (2008) A Compendium of 500 Species, Vol. 3, pp.107-109, Orient Longman Ltd., Madras.
15. Jacobs, C., Kayser, O. and Muller, R.H. (2001) 'Production and characterisation of muco adhesive nanosuspensions for the formulation of bupravaquone', Int. J. Pharm., Vol. 214, pp.3-7.
16. Jinno, J., Kamada, N., Miyake, M., Yamada, K., Mukai, T., Odomi, M., Toguchi, H., Liversidge, G.G., Higaki, K. and Kimura, T. (2006) 'Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs', J. Control Release, Vol. 111, pp.56-64.
17. Kapoor, L.D. (1999) CRC Handbook of Ayurvedic Medicinal Plants, pp.200-211, CRC Press, Boca Raton, FL.
18. Keck, C., Fichtinger, A., Viernstein, H. and Muller, R.H. (2004) 'Oral drug nanocrystals-effect of potential aggregation on bioavailability', Annual Meeting of Pharmaceutical Scientists (AAPS), p. 2746, Baltimore.
19. Keshavamurthy, K.R. and Yoganarasimhan, S.N. (2008) Flora of Coorg - Karnataka, pp.282-296, Vimsat publishers, Bangalore.
20. Kinghorn, A.D. and Compadre, C.M. (2003) 'Less common high-potency sweeteners', in Nabors, L.O. (Ed.): Alernative Sweeteners: Second Edition, Revised and Expanded, ISBN 0-8247-8475-8, New York.
21. Kipp, J.E.,Wong, J.C.T., Doty, M.J. and Rebbeck, C.L. (2003) Micro Precipitation Method for Preparing Sub Micron Suspensions, United States Patent 6,607,784.
22. Kuzuko, Y., Kayoko, A., Shigenoby, A. and Kouji, M. (1989) 'Structure studies of new anitsweet constituents from gymnema sylvestris', Tetrahedron Lett., Vol. 30, No. 9, pp.1130-1106.
23. List, M. and Sucker, H. (1988) Pharmaceutical Colloidal Hydrosols for Injection, GB Patent 2,200,048.
24. Liu, B., Asare-Anane, H., Al-Romaiyan, A., Huang, G., Amiel, S.A., Jones, P.M. and Persaud, S.J. (2009) 'Characterisation of the insulinotropic activity of an aqueous extract of gymnema sylvestre in mouse β-cells and human islets of langerhans', Cellular Physiology and Biochemistry, Vol. 23, pp.125-132.
25. Liversidge, G.G. and Conzentino, P. (1995) 'Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats', Int. J. Pharm., Vol. 125, pp.309-313.
26. Liversidge, G.G. and Cundy, K.C. (1995) 'Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs', Int. J. Pharm., Vol. 125, pp.91-97.
27. Liversidge, G.G., Phillips, C.P. and Cundy, K.C. (1994) Method to Reduce Particle Size Growth during Lyophilization, United States Patent 5,302,401.
28. Muller, R.H. and Akkar, A. (2004) 'Drug nanocrystals of poorly soluble drugs', in Nalwa, H.S. (Ed.): Encyclopedia of Nanoscience and Nanotechnology, American Scientific Publishers, pp.627-638.
29. Muller, R.H., Becker, R., Kruss, B. and Peters, K. (1999) Pharmaceutical Nanosuspensions for Medicament Administration as Systems with Increased Saturation Solubility and Rate of Solution, United States Patent 5,858,410.
30. Müller, R.H., Böhm, B.H.L. and Grau, M.J. (1999) 'Nanosuspensions - formulations for poorly soluble drugs with poor bioavailability/2nd communication: stability, biopharmaceutical aspects, possible drug forms and registration aspects', Pharm. Ind., Vol. 61, No. 2, pp.175-178.
31. Muller, R.H., Jacobs, C. and Kayser, O. (2000) 'Nanosuspensions for the formulation of poorly soluble drugs', in Nielloud, F. and Marti-Mestres, G. (Eds.): Pharmaceutical Emulsions and Suspensions, pp.383-407, Marcel Dekker.
32. Muller, R.H., Jacobs, C. and Kayser, O. (2001) 'Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future', Adv. Drug Deliv. Rev., Vol. 47, pp.3-19.
33. Muller, R.H., Mäder, K. and Krause, K. (2000) Verfahren zur schonenden Herstellung vonhochfeinen Micro-/Nanopartikeln, PCT Application PCT/EP00/06535.
34. Munoz, N., Ferrero, C., Munoz-Ruiz, A., Velasco, M.V. and Jimenez-Castellanos, M.R. (1998) 'Effect of explotab on the tabletability of a poorly soluble drug', Drug Dev. Ind. Pharm., Vol. 24, pp.785-791.
35. Noyes, A.A. and Whitney, W.R. (1897) 'The rate of solution of solid substances in their own solutions', J. Am. Chem. Soc., Vol. 19, pp.930-934.
36. Petersen, R.D. (2006) Nanocrystals for Use in Topical Formulations and Method of Production there of, PCT/EP2007/009943.
37. Public Health Service (2000) 'USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with HIV: Part II. Prevention of the first episode of disease', Am Fam Physician, Vol. 61, pp.441-442, 445-449, 453-454.
38. Rajpal, V. (2002) Standardization of Botanicals-testing and Extraction Methods of Medicinal Herbs, Vol. 1, pp.140-148, Eastern Publishers, New Delhi.
39. Rao, M.Y., Kumar, M. and Apte, S. (2008) 'Formulation of nanosuspensions of albendazole for oral administration', Curr. Nanosci., Vol. 4, pp.53-58.
40. Ravichandran, R. (2009a) 'Nanoparticles in drug delivery: potential green nanobiomedicine applications', International Journal of Green Nanotechnology: Biomedicine, B108-B130, doi:10.1080/19430850903430427.
41. Ravichandran, R. (2009b) 'Nanotechnology-based drug delivery systems', NanoBiotechnology, Vol. 5, No. 1, pp.17-33, doi:10.1007/s12030-009-9028-2.
42. Sandhya, B., Thomas, S., Isabel, W. and Shenbagarathi, R. (2006) 'Ethanomedicinal plants used by the valaiyan community of piranmalai hills (reserved forest), Tamil Nadu, India: a pilot study', Afr. J. Trad. Compl. Alter. Med., Vol. 3, pp.101-114.
43. Schöler, N., Krause, K., Kayser, O., Muller, R.H., Hartwig, H., Hahn, H. and Liesenfeld, O. (2001) 'Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis', Antimicrob. Agents Chemother., pp.1771-1779.
44. Sucker, H. and Gassmann, P. (1994) Improvements in Pharmaceutical Compositions, European Patent 0,580,690.
45. Takagi, H., Kajiyama, A. and Yanagisawa, M. (2007) Rapidly Disintegrable Pharmaceutical Composition, United States Patent 7,189,415.
46. Takano, R., Furumoto, K., Shiraki, K., Takata, N., Hayashi, Y., Aso, Y. and Yamashita, S. (2008) 'Rate-limiting steps of oral absorption for poorly water-soluble drugs in dogs; prediction from a mini scale dissolution test and a physiologically-based computer simulation', Pharm. Res., pp.99-104.
47. Venkatesan, G.K. and Krishnan, K. (2009) 'Anticancer-cytotoxic activity of saponins isolated from the leaves of gymnema sylvestre and eclipta prostrata on HeLa cells', Int. J. Gren. Pharm., Vol. 3, No. 3, pp.227-229.
48. Warren, R.P., Warren, R.M. and Weninger, M.G. (1969) 'Inhibition of the sweet taste by gymnema sylvestre', Nature, Vol. 223, pp.94-95.
49. Wu, T.H., Yen, F.L., Lin, L.T., Tsai, T.R., Lin, C.C. and Cham, T.M. (2008) 'Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles', Int. J. Pharm., Vol. 346, pp.160-168.
50. Ye, W., Liu, X., Zhang, Q., Che, C.T. and Zhao, S. (2001) 'Antisweet saponins from gymnema sylvestre', J. Nat. Prod., Vol. 64, pp.232-235.